Respiratory Syncytial Virus Infections

• CLINICAL_TRIALS trial_result · 2018-08-20
  Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults [Phase 1]

  Phase 1 trial assessing safety and immunogenicity of GSK's RSV vaccine ChAd155-RSV (GSK3389245A) in healthy adults completed with results po…

• CLINICAL_TRIALS trial_result · 2018-07-02
  Clinical Trial Update: A Study of AK0529 in Infants Hospitalized With RSV [Phase 1]

  A Phase 1 trial of the RSV therapy AK0529 in infants hospitalized with Respiratory Syncytial Virus infections was terminated.

• CLINICAL_TRIALS trial_result · 2018-05-16
  Clinical Trial Update: A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study [Phase 1, Phase 2]

  Completed Phase 1/2 study evaluating antiviral activity, safety, and pharmacokinetics of multiple doses of PC786 in an RSV challenge model.

• CLINICAL_TRIALS trial_result · 2018-02-05
  Clinical Trial Update: Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

  Phase 2b trial update for ALN-RSV01 in lung transplant patients with RSV infection has been completed.

• CLINICAL_TRIALS trial_result · 2018-01-29
  Clinical Trial Update: Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

  Phase 2 study update for ALN-RSV01 in lung transplant patients with RSV infection completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-11-28
  Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults [Phase 1]

  This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of MEDI8897 in healthy adults to support further development for…

• CLINICAL_TRIALS trial_result · 2016-08-10
  Clinical Trial Update: Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine [Phase 1]

  A Phase 1 trial evaluating the safety, tolerability and immunogenicity of Bavarian Nordic's Recombinant MVA BN RSV Vaccine has completed.

• CLINICAL_TRIALS trial_result · 2016-07-11
  Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants [Phase 1]

  Phase 1 study evaluating safety, tolerability, and pharmacokinetics of ALS-008176 in healthy Japanese adults for respiratory syncytial virus…

• CLINICAL_TRIALS trial_result · 2016-06-01
  Clinical Trial Update: Assessment of Airway Obstruction in Infants With Lower Respiratory Infections [NA]

  ClinicalTrials.gov update notes the trial assessing airway obstruction in infants with bronchiolitis and RSV infections has completed. Resul…

• CLINICAL_TRIALS trial_result · 2016-05-26
  Clinical Trial Update: RSV F Dose-Ranging Study in Women [Phase 2]

  Phase 2 dose-ranging trial of an RSV F protein-based vaccine in women has completed.

• CLINICAL_TRIALS trial_result · 2015-12-15
  Clinical Trial Update: Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children [Phase 1]

  Phase 1 trial evaluating the safety and immune response of an RSV vaccine across adults, RSV-seropositive children, and RSV-seronegative inf…

• CLINICAL_TRIALS trial_result · 2015-10-08
  Clinical Trial Update: Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [Phase 1]

  A completed Phase 1 trial evaluated the safety and immune response of a live-attenuated RSV vaccine in RSV-seronegative infants and children…

• CLINICAL_TRIALS trial_result · 2015-08-21
  Clinical Trial Update: Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

  Phase 2 safety and efficacy study of GS-5806 (presatovir) in healthy volunteers infected with respiratory syncytial virus has completed.

• CLINICAL_TRIALS trial_result · 2010-08-27
  Clinical Trial Update: Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [Phase 3]

  This update notes the termination of a Phase 3 trial evaluating ribavirin to prevent RSV pneumonia in bone marrow transplant patients.

• CLINICAL_TRIALS trial_result · 2007-11-30
  Clinical Trial Update: Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus [Phase 2]

  A Phase 2 trial evaluating intranasal ALN-RSV01 in healthy adult volunteers experimentally inoculated with respiratory syncytial virus has c…

• CLINICAL_TRIALS trial_result · 2007-07-03
  Clinical Trial Update: Study to Evaluate MEDI-534 in Healthy Adults

  This completed study evaluated MEDI-534 in healthy adults to assess safety for Respiratory Syncytial Virus and Parainfluenza infections.